Colorado Springs, CO1 Active Studies

Chronic Spontaneous Urticaria Clinical Trials in Colorado Springs, CO

Find 1 actively recruiting chronic spontaneous urticaria clinical trials in Colorado Springs, CO. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
200
Enrolling

Recruiting Chronic Spontaneous Urticaria Studies in Colorado Springs

About Chronic Spontaneous Urticaria Clinical Trials in Colorado Springs

Chronic spontaneous urticaria involves the recurrence of hives and/or angioedema for more than six weeks without an identifiable external trigger. It significantly impacts quality of life. Treatment includes second-generation antihistamines and biologics like omalizumab.

There are currently 1 chronic spontaneous urticaria clinical trials recruiting participants in Colorado Springs, CO. These studies are seeking a combined 200 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Spontaneous Urticaria Clinical Trials in Colorado Springs — FAQ

Are there chronic spontaneous urticaria clinical trials in Colorado Springs?

Yes, there are 1 chronic spontaneous urticaria clinical trials currently recruiting in Colorado Springs, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What chronic spontaneous urticaria treatments are being tested?

The 1 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for chronic spontaneous urticaria.

Data updated October 15, 2026 from ClinicalTrials.gov